Brivaracetam

Brand names: BRIVIACT BRIVLERA

Therapeutic Indications

Brivaracetam is indicated for:

at least one of

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

Complex partial status epilepticus

For this indication, the medical literature mentions below treatments (click for details):

Active ingredient Brivaracetam is contraindicated in the following cases:

Next: Precautions >